| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 216.91▼ | 217.09▼ | 216.83▼ | 216.84▼ | 217.75▼ |
| MA10 | 216.99▼ | 217.12▼ | 217.59▼ | 216.09▼ | 211.77▲ |
| MA20 | 217.28▼ | 217.62▼ | 217.21▼ | 217.87▼ | 205.85▲ |
| MA50 | 217.19▼ | 216.92▼ | 216.65▼ | 210.57▲ | 187.85▲ |
| MA100 | 217.68▼ | 216.32▼ | 217.41▼ | 203.87▲ | 164.03▲ |
| MA200 | 217.32▼ | 217.55▼ | 215.87▼ | 192.84▲ | 206.95▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.130▼ | -0.201▼ | -0.167▼ | -0.643▼ | 0.254▲ |
| RSI | 30.618▼ | 39.035▼ | 43.626▼ | 50.439▲ | 61.751▲ |
| STOCH | 45.671 | 28.651 | 26.683 | 50.696 | 79.237 |
| WILL %R | -90.909▼ | -94.923▼ | -92.841▼ | -60.564 | -25.502 |
| CCI | -289.988▼ | -149.939▼ | -125.403▼ | -5.632 | 80.552 |
|
Thursday, September 17, 2026 01:15 PM
Biogen Inc. (Nasdaq: BIIB) announced the publication of results from a prespecified adolescent subgroup analysis of its Phase 3 VALIANT study evaluating Empaveli (pegcetacoplan) in the Clinical ...
|
|
Tuesday, September 15, 2026 12:47 PM
Wolfe Research upgraded two prominent pharmaceutical companies to Outperform on August 13. The firm upgraded both Biogen Inc. (NASDAQ:BIIB) and AbbVie Inc. (NYSE:ABBV)’s ratings from Peer Perform, ...
|
|
Tuesday, September 15, 2026 12:47 PM
Wolfe Research upgraded two prominent pharmaceutical companies to Outperform on August 13. The firm upgraded both Biogen Inc. (NASDAQ:BIIB) and AbbVie Inc. (NYSE:ABBV)’s ratings from Peer Perform, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/09/26 | 219.05 | 220.17 | 215.26 | 215.50 | 2,634,700 |
| 17/09/26 | 216.995 | 219.405 | 215.34 | 219.065 | 575,842 |
| 16/09/26 | 216.41 | 218.29 | 214.81 | 216.01 | 606,500 |
| 15/09/26 | 217.205 | 217.205 | 213.79 | 216.28 | 547,918 |
| 14/09/26 | 221.00 | 222.25 | 215.56 | 217.36 | 629,900 |
| 11/09/26 | 216.75 | 219.76 | 214.71 | 217.15 | 1,075,600 |
| 10/09/26 | 209.92 | 216.70 | 208.93 | 215.43 | 936,600 |
| 09/09/26 | 210.50 | 213.48 | 209.00 | 210.73 | 694,600 |
| 08/09/26 | 215.45 | 217.28 | 210.54 | 212.50 | 617,600 |
| 04/09/26 | 221.15 | 223.82 | 219.82 | 220.83 | 465,100 |
|
|
||||
|
|
||||
|
|